Pharma By The Numbers: Celebrating 20 Years of Xtalks with an Analysis of the Industry

In this episode, Xtalks’ senior editorial staff discuss how the pharmaceutical industry has changed – and stayed the same – in the last 2 decades. Sarah talks about the global value of the pharmaceutical industry in 2002 versus today and which companies made the top 3 based on revenue. Sarah also shared the top-selling drugs in 2002, 2012 and 2022, and how much the industry as a whole has invested in R&D in those years. The team discusses the number of new drugs and biologics approved by the FDA each year, and debates whether the regulator will be able to keep up with growing submission numbers and the expectation of speedy approval decisions.  The team also talked about the role of Xtalks in knowledge dissemination and facilitating meaningful conversations in the pharma industry through webinars, written content, videos and, of course, this podcast! To read more, visit Pharma By The Numbers: A Retrospective Look at the Industry and 20 Years of Xtalks History. For a closer look at the stats discussed in this episode, check out this infographic. For more life science and medical device content, visit the Xtalks Vitals homepage. Follow Us on Social Media Twitter: @Xtalks Instagram: @Xtalks Facebook: https://www.facebook.com/Xtalks.Webinars/ LinkedIn: https://www.linkedin.com/company/xtalks-webconferences YouTube: https://www.youtube.com/c/XtalksWebinars/featured